Published in
Wiley Open Access, Bioengineering and Translational Medicine, 1(5), 2020
DOI: 10.1002/btm2.10152
Links
Tools
CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1 ‐mutated breast cancer cells
Journal article published in 2020 by
Rachel L. Mintz,
Yeh‐Hsing Lao 
,
Chun‐Wei Chi,
Siyu He,
Mingqiang Li ,
Chai Hoon Quek,
Dan Shao,
Boyuan Chen,
Jing Han,
Sihong Wang,
Kam W. Leong
,
Chun‐Wei Chi,
Siyu He,
Mingqiang Li ,
Chai Hoon Quek,
Dan Shao,
Boyuan Chen,
Jing Han,
Sihong Wang,
Kam W. Leong
This paper is made freely available by the publisher.
Full text: Download
Data provided by 